Published as supplied by the author
Web extra references
w1 Health and Social Care Information Centre. Hospital Prescribing, 2004: England. www.ic.nhs.uk/pubs/hosppresc2004/doc/file (accessed 13 April 2006).
w2 NICE. Developing NICE technology appraisals. www.nice.org.uk/page.aspx?o=297101 (accessed 12 April 2006).
w3 NICE. Draft Scope - Macular degeneration (age-related). www.nice.org.uk/page.aspx?o=298551 (accessed 12 April 2006).
w4 Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L et al. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J Clin Oncol 1996;14:737-44.
w5 Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;344:783-92.
w6 Genentech. Study Published In New England Journal Of Medicine Demonstrates Herceptin With Chemotherapy Increases Median Survival In Women With Metastatic Breast Cancer. www.gene.com/gene/news/press-releases/display.do?method=detail&id=4649 (accessed 12 April 2006).
w7 Breakthrough Boosts Breast Cancer Hopes. The Express 2001 March 16;4.
w8 NICE. Clinical effectiveness and cost utility of photodynamic therapy for wet age-related macular degeneration. www.nice.org.uk/page.aspx?o=30223 (accessed 12 April 2006).
w9 Link Pharmaceuticals. Nice Poised to Deny Brain Tumour Patients Access to Latest Breakthrough Treatments. www.prnewswire.co.uk/cgi/news/release?id=164552 (accessed 13 April 2006).
w10 Pfizer Ltd. Sad day for patients. NICE decision to refuse patients access to inhaled insulin is a set back for people with diabetes and their physicians. www.pfizer.co.uk/template2.asp?pageid=335 (accessed 13 April 2006).
w11 Shire plc. NICE request for data on subgroups of Alzheimer’s patients more likely to benefit from therapy could lead to guidance that deprives thousands of essential treatment. www.shire.com/shire/NewsAndMedia/PressReleases/showShirePress.jsp?ref=441&tn=3&ml=8&m2= (accessed 12 April 2006).
w12 Spink J. How can PR handle NICE? Communiqué 2001. www.pmlive.com/archive.cfm?&ArticleID=540&back=-1 (accessed 12 April 2006).
w13 Jeffries M. The mark of Zorro. Pharmaceutical Marketing 2005. www.pmlive.com/index.cfm?showArticle=1&ArticleID=445 (accessed 12 April 2006).
w14 Patient View. Fundraising and the growth of industry involvement. Health and Social Campaigners’ News 2004.
w15 Help the Aged. Thank You. http://corporate.helptheaged.org.uk/_corporate/_thanks_list.htm (accessed 12 April 2006).
w16 Breast Cancer Care. Full supporters list. www.breastcancercare.org.uk/content.php?page_id=2067 (accessed 12 April 2006).
w17 Breakthrough Breast Cancer. Our partners. www.breakthrough.org.uk/you_can_help/companies_and_employees/our_partners/index.html (accessed 13 April 2006).
w18 Alzheimer’s Disease International. NICE guidelines - dementia drugs may longer be recommended. www.alz.co.uk/media/nr050301.html (accessed 12 April 2006).
w19 Alzheimer’s Society. Drugs for the treatment of Alzheimer’s disease - A summary of the Alzheimer’s Society’s response to draft guidance from Nice (the National Institute for Clinical Excellence). www.alzheimers.org.uk/News_and_Campaigns/PDF/Summary_Niceresponse_DrugsforAlzheimers.pdf (accessed 14 April 2006).
w20 Action on Alzheimer’s Drugs alliance. Drug treatments which help thousands of people with Alzheimer’s disease are under serious threat. www.handsoffdementiadrugs.org (accessed 12 April 2006).
w21 National Osteoporosis Society. National Osteoporosis Society criticises NICE proposal to cut back on treatments. http://www.nos.org.uk/news/media-archive-2004.htm (accessed 11 May 2006).
w22 Diabetes UK. Guidance published on use of inhaled insulin. www.diabetes.org.uk/onlinenews/NewsStory.asp?id=1594 (accessed 20 April 2006).
w23 Women fighting for herceptin. www.fightingforherceptin.org.uk (accessed 18 April 2006).
w24 Shropshire six. www.shropshiresix.com/main.asp (accessed 19 April 2006).
w25 Breakthrough Breast Cancer. Breakthrough Comment: Ann Marie Rogers wins Herceptin appeal. www.breakthrough.org.uk/who_we_are/media_centre/breakthrough_48.html (accessed 13 April 2006).
w26 NHS chiefs in U-turn over cancer wonderdrug. Manchester Evening News 2001 August 25;2.
w27 M.E.N. wins U-turn over cancer drug. Manchester Evening News 2001 August 25;1.
w28 Drug care campaign wins MEN a trophy. Manchester Evening News 2001 October 18;2.
w29 Oliver, S. Camilla throws a house party. Mail on Sunday (London) 1995 September 24;1.
w30 Rayner C. A shameful betrayal. Daily Mail (London) 2005 October 6;6.
w31 Steven S. Why save lives when you can save money? Mail on Sunday 2001 August 12;51.
w33 Stuttaford T. Alzheimer’s and the need for swift treatment. The Times 2006 January 30;11.
w34 House of Commons. Questions for Oral or Written Answer (The "Question Book") www.publications.parliament.uk/pa/cm/cmordbk.htm (accessed 13 April 2006).
w35 Revill, J. Ministers reprieve Alzheimer’s treatment. The Observer 2005 March 13;2.
W36 Department of Health. Speech by Rt Hon Patricia Hewitt MP, Secretary of State for Health, 25th October 2005: Breast Cancer Awareness. www.dh.gov.uk/NewsHome/Speeches/SpeechesList/SpeechesArticle/fs/en?CONTENT_ID=4121929&chk=AEiAHr (accessed 12 April 2006).